Navigation Links
Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
Date:5/15/2008

beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMEA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such products candidates, the absence of guarantee that the products candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives as well as those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward- Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2007. Other than as required by applicable law, sanofi- aventis does not undertake any obligation to update or revise any forward- looking information or statements.

Contact:

Marisol Peron, sanofi-aventis

P: 908-981-6565

E-mail: marisol.peron@sanofi-aventis.com

Amy Ba, sanofi-aventis

P: 908-981-6563

E-mail: amy.ba@sanofi-aventis.com


'/>"/>
SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial
2. Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
3. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
4. Hospital Launches Landmark Emergency Medicine Project
5. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
6. Viatronix V3D-Colon Utilized in Another Landmark Study
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
9. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
10. Ceremeds OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
11. St. Jude Study Shows How T Cells Machinery Dials Down Autoimmunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Fla. , Dec. 19, 2014 Breckenridge ... a multi-product agreement with MSN Laboratories Pvt. Ltd. ( ... MSN expect to commercialize several new ANDAs.  Under the ... supply the products exclusively to Breckenridge for the U.S. ... under its label.  Breckenridge and MSN have agreed to ...
(Date:12/19/2014)... , Dec. 19, 2014  Monarch America Inc. (OTCQB: ... Corp.) is pleased to provide this review of the ... in 2015. "Over this past year, we ... I am extremely proud to say that Monarch America ... than it has ever been," stated Eric Hagen ...
(Date:12/19/2014)... DUBLIN , Dec. 18, 2014 Research ... announced the addition of the "Micro Market ... report to their offering. ... dermatological treatment is progressing steadily, which has resulted ... diagnostic devices market. The main purpose of these ...
Breaking Medicine Technology:Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3
... 2007 - Geron,Corporation (Nasdaq:GERN) today announced the ... company's human,embryonic stem cell (hESC)-based therapeutic for ... direct attack by the human immune,system., Presented ... Federation of,Clinical Immunology Societies meeting in San ...
... BETHESDA, Md., June 11, 2007--New research supported ... of Arthritis and,Musculoskeletal and Skin Diseases (NIAMS) ... which is used for certain,types of seizures, ... pain and,other symptoms associated with the common, ...
Cached Medicine Technology:Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 2Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 3Gabapentin Shown Effective for Fibromyalgia Pain 2Gabapentin Shown Effective for Fibromyalgia Pain 3
(Date:12/20/2014)... Francisco, CA (PRWEB) December 20, 2014 ... Social Innovation company just launched first birthday focused portal ... services, “MERRY BIRTHDAY MESSAGE” launched in both US and ... MERRY BIRTHDAY MESSAGE : http://merrybirthday.net/message/ , MERRY ... for everyone’s birthday around the world. , Features, Choose ...
(Date:12/20/2014)... Aliso Viejo, California (PRWEB) December 20, 2014 ... have announced the release of a new plugin for ... Pixel Film Studios. , “TranSlice Volume 5 allows users ... literally hand draw it.” Said Christina Austin, CEO of ... to add level of professionalism while maintaining an easy ...
(Date:12/20/2014)... Parker & Sons, Inc. a focused ... experience in contractor services announces reaching a milestone by ... homeowners of Arizona. Parker and Sons is comprised of ... that make customer service the number one priority. The ... started with one service vehicle and has since grown ...
(Date:12/19/2014)... It’s very easy to become overwhelmed with ... put to the wayside until Christmas and the New Year ... “itch” and that burning desire to just escape it all ... journey to Telluride with a no-fuss, affordable package. Montrose Days ... the resort, and ensure that all accommodations are met. Plus, ...
(Date:12/19/2014)... December 19, 2014 Energy Textiles ... are now available. Celliant, the world’s leading responsive ... and pillowcases. , There are a number of ... circulation, increased oxygenation and balanced body temperature; which ... and pain relief; enhanced athletic performance; and overall ...
Breaking Medicine News(10 mins):Health News:Atore, Inc. Releasing the First Birthday Portal 2Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 3Health News:Days Inn Montrose Colorado Delivers Last Minute Holiday Season Ski Getaway Accommodations 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2
... Calif., Nov. 6 Nationwide,Health Properties, Inc. (NYSE: ... 2007 operating results and investment activity. "The third ... up 28% and,normalized FFO per share up 8%," commented ... the quarter we closed $150,million of accretive investments, bringing ...
... The Disabled American,Veterans (DAV) is commending lawmakers ... largest increase in funding for the Department of,Veterans ... Congress and the,Administration to support this important legislation ... Construction and Veterans Affairs Appropriations bill,calls for an ...
... American Public,Health Association today adopted 20 policies addressing ... safety and obesity to personal hygiene and,global climate ... of the various measures approved,by the Association,s Governing ... Nov. 3-7. Full policies will be available online ...
... Canadian researchers expect to accelerate the war on cancer by ... people who volunteer their idle computer time to tackle some ... team, led by Dr. Igor Jurisica at the Ontario Cancer ... Health Network, are the first from Canada to use the ...
... NY Scientists at Cold Spring Harbor Laboratory (CSHL) ... from the human genome that is more powerful and more ... selective resequencing, promises to be a boon to many kinds ... genome for mutant genes implicated in major diseases such as ...
... Programs During the Quarter, PALO ALTO, Calif., Nov. ... announced financial results for,the quarter ended September 30, 2007. ... of 2007 was $19.4,million, compared to net income of ... in the quarter ended September 30, 2006 included $31.6,million ...
Cached Medicine News:Health News:NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information 2Health News:NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information 3Health News:NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information 4Health News:NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information 5Health News:NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information 6Health News:NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information 7Health News:NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information 8Health News:NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information 9Health News:NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information 10Health News:NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information 11Health News:NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information 12Health News:VA Budget Earns High Praise 2Health News:APHA Adopts New Policies on Food Safety, Global Climate Change, Multidrug-Resistant Organisms, Breastfeeding and Feminine Hygiene 2Health News:APHA Adopts New Policies on Food Safety, Global Climate Change, Multidrug-Resistant Organisms, Breastfeeding and Feminine Hygiene 3Health News:APHA Adopts New Policies on Food Safety, Global Climate Change, Multidrug-Resistant Organisms, Breastfeeding and Feminine Hygiene 4Health News:IBM world community grid squeezes decades of cancer research into 2 years 2Health News:Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 2Health News:Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 3Health News:Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 4Health News:Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 5Health News:Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 6Health News:Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 7Health News:Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 8Health News:Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 9Health News:Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results 10
Inquire...
... incubators,Two refrigerated incubators that are ... life cycle,testing. Microprocessor controlled heating ... display. High/low audible and visual ... internal chamber safety thermostat,provides over-temperature ...
Inquire...
Inquire...
Medicine Products: